Quantcast

Latest osteopenia Stories

2010-11-18 17:11:06

Taking time off from certain osteoporosis drugs may be beneficial to bone health, according to a study conducted at Loyola University Health System. Researchers found that bone density remained stable for three years in patients who took a drug holiday from bisphosphonates, a popular class of osteoporosis drugs that can cause fractures in the thigh bones and tissue decay in the jaw bone. "These drugs are potentially harmful when taken for long durations, yet little has been known until now...

2010-10-18 16:02:17

Vital that those caring for IBD patients evaluate for vitamin D nutritional deficiency Vitamin D deficiency puts patients with Inflammatory Bowel Disease (IBD) at greater risk of osteoporosis, osteopenia and an overall higher rate of abnormal bone density, according to the results of a new study unveiled today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas. The study, "Vitamin D Deficiency and Abnormal DEXA Scans in Inflammatory Bowel...

2010-07-14 15:34:12

A comprehensive Argentinean epidemiological study reveals the staggering costs of osteoporosis in the country. The key findings of the article published in April 2010 in the scientific journal "Archives of Osteoporosis", include:"¢ In Argentina, bone mineral density studies reveal that one out of three women aged 50 or over suffers from osteoporosis."¢ The prevalence of vertebral fractures in Argentinean women aged 50 or older is 16%."¢ Over 34.000 hip fractures occur every...

2010-07-06 08:00:00

WALTHAM, Mass., July 6 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launch and uptake of Amgen/GlaxoSmithKline's Prolia will drive this agent to garner sales of more than $500 million in 2019 for postmenopausal osteoporosis in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Additional sales of Prolia will come from a number of oncology-related indications,...

2010-06-28 01:57:00

MUNICH, June 28, 2010 /PRNewswire/ -- - 3D Images Provide New Approach to Monitoring Bone Changes Interim data from a prospective Investigator Initiated Trial (IIT) presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA(R) (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated for the treatment and prevention of osteoporosis in postmenopausal women, improves bone quality as measured by...

2009-12-14 08:00:00

CLEVELAND, Dec. 14 /PRNewswire/ -- According to a new survey distributed by The North American Menopause Society (NAMS), while 98 percent of women who participated consider bone strength to be an important health concern, nearly half (45 percent) of these women reported that osteoporosis was not addressed during their last routine OB/GYN visit, and more than a quarter (26.4 percent) of women surveyed have never discussed osteoporosis with their OB/GYN. More than 880 women completed the...

2009-12-03 07:00:00

WALTHAM, Mass., Dec. 3 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the majority of surveyed clinicians say they will use Amgen/GlaxoSmithKline's Prolia as either a second- or third-line therapy for osteoporosis if the drug receives regulatory approval for the indication. Prolia, which is expected to receive approval from the Food and Drug Administration in early 2010, will be prescribed in...

2009-11-04 19:08:42

Osteoporosis Linked to Bronchiectasis(#8660, Monday, November 2, 1:30 PM ET) Patients with non-cystic fibrosis bronchiectasis may have a high incidence of osteopenia and osteoporosis. Researchers from Scott & White Hospital and Texas A&M Health Science Center College of Medicine in Texas reviewed the records of 113 patients admitted to the hospital with acute exacerbation of bronchiectasis. The mean age of the patients was 63 years, 76 percent were Caucasian, and 70 percent were...

2009-06-01 00:15:00

- Single infusion of Reclast increases bone mass for two years in postmenopausal women with osteopenia, a condition that can lead to osteoporosis(1) - Approximately 22 million women in US have osteopenia, or low bone mass, putting them at increased risk of fractures of hip, spine and wrist(2,3) - Reclast already approved as once-yearly infusion for treatment of postmenopausal osteoporosis(1) EAST HANOVER, N.J., June 1 /PRNewswire/ -- Reclast(R) (zoledronic acid) Injection has been approved...

2009-03-26 10:31:08

People with osteoporosis are much more likely to experience vertigo, an inner ear disorder that causes dizziness. This suggests a problem with calcium metabolism in vertigo sufferers, according to a new study. Doctors believe loose calcium carbonate crystals that move in the sensing tubes of the inner ear cause vertigo. For the study, Korean researchers recruited 209 people with vertigo with no known cause such as head trauma or ear surgery and 202 people with no history of dizziness. They...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related